UNIQURE N.V. (QURE)
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
Oatly and Nespresso Return to Bring the Iced Coffee Experience Home
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
Press Release: Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies
Multi Ways Holdings Files Annual Report on Form 20-F for Fiscal Year 2025
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
Western Midstream Announces Start-up of Second Produced-Water Treatment Facility in the Permian Basin
ARMLOGI HOLDING CORP. ADVANCES OPERATIONAL READINESS AND NETWORK CAPACITY INITIATIVES AHEAD OF SUMMER PEAK COMMERCE SEASON
Lithium Ionic to Present at the Fastmarkets Global Lithium, Battery & Critical Materials Conference in Las Vegas